Shareholding3 Oct 2026, 06:10 pm
Aarey Drugs Promoters Acquire 2.37 Mn Shares; Net Holding Down 1.74%
AI Summary
Aarey Drugs & Pharmaceuticals Ltd's promoter and promoter group acquired 2,370,000 equity shares through the conversion of warrants. These acquired shares represent 7.71% of the company's total post-acquisition share capital. Despite this acquisition, the promoter group's overall shareholding percentage decreased from 37.71% to 35.97%, a net reduction of 1.74%. This indicates a significant increase in the total diluted share capital. Key individuals like Bina Rajesh Ghatalia, Mihir Rajesh Ghatalia, Nimit Rajesh Ghatalia, Mira Mihir Ghatalia, Ekta Nimit Ghatalia, Mihir Rajesh Ghatalia (HUF), and Rajesh Pranlal Ghatalia all increased their individual shareholdings through this conversion.
Key Highlights
- Promoter group acquired 2.37 million shares via warrant conversion.
- The acquired shares represent 7.71% of the post-acquisition share capital.
- Net promoter group holding decreased by 1.74% (from 37.71% to 35.97%).
- Individual promoter holdings increased in absolute shares and percentage.
- The acquisition is disclosed under SEBI SAST Regulations, 2011.
Price Impact
More from AAREYDRUGS